Rouland, Alexia
Inserm · Université de Bourgogne · CHU Dijon Bourgogne · Centre de recherche Translationnelle en Médecine moléculaire
3 papers on CoChatORCID 0000-0003-0727-2052
Most cited papers
- Verified
Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus
Vergès, B., Duvillard, L., Pais de Barros, J. P., Bouillet, B., Baillot-Rudoni, S., Rouland, A., Sberna, A.-L., Petit, J.-M., Degrace, P., & Demizieux, L. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology
Lipid metabolism and disordersDiabetes Treatment and Management
Cited by 75
- Verified
Liraglutide Increases the Catabolism of Apolipoprotein B100–Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression
Vergès, B., Duvillard, L., Pais de Barros, J. P., Bouillet, B., Baillot-Rudoni, S., Rouland, A., Petit, J. M., Degrace, P., & Demizieux, L. (2021) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health
Cited by 54
- Verified
Frequent and severe hypoglycaemia detected with continuous glucose monitoring in older institutionalised patients with diabetes
Bouillet, B., Tscherter, P., Vaillard, L., Nonciaux, C., Hourdain, P., Ravier, A., Rouland, A., Petit, J. M., Vergès, B., & Quilot, E. (2021) · Age and Ageing
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 29
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free